Although the percentage of NHEJ remaining after DNA-PK inhibition was high (around 50%, in agreement with a previous report using DNA-PK mutants [41]), no significant differences were observed between MM and control LINF cells (Fig. 6I). The gene discussed is PRKDC; the disease is Miyoshi myopathy.